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Freshly isolated mouse prostate epithelial cells regenerate fully differentiated prostate tissue when combined with embryonic urogenital sinus
mesenchyme and grafted in vivo. We show here that this regenerative capacity, which has been attributed to a small population of pleuripotential
progenitor epithelial cells, is rapidly lost when the cells are placed in monolayer culture but can be maintained by culture in anchorage-
independent conditions. Epithelial cells placed in anchorage-independent culture formed proliferating spheres that could be serially passaged and
exhibited increased expression of putative stem cell markers as compared to cells grown in monolayer culture. Epithelial cells isolated from the
fetal urogenital sinus, the newborn, and adult prostate formed spheres with similar efficiency, while cells isolated from the post-castration prostate
exhibited significantly higher sphere-forming abilities. When passaged spheres were recombined with E17 rat urogenital sinus mesenchyme and
grafted in vivo, they generated fully differentiated mouse prostate glandular epithelium containing both p63+ basal cells and p63− luminal cells
and expressing a variety of prostate-specific and terminal differentiation markers.
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The adult mouse prostate is a male accessory sex organ
located near the base of the urinary bladder. It is composed of
distinct anterior, dorsal, and ventral lobes that surround the male
urethra and contribute androgen-dependent secretory proteins to
the ejaculate. The origin of the secretory ducts is the prostatic
anlagen of the urogenital sinus (UGS). The UGS is comprised
of two layers: an outer layer of mesenchyme and an inner layer
of stratified epithelium (Price, 1963; Wang et al., 2001). In
mouse, epithelial buds invade the surrounding mesenchyme and
give rise to the main ducts of the prostatic ductal system at
E17.5. This is an androgen-induced event, and under the
continued influence of testosterone, the main prostatic ducts
undergo extensive branching morphogenesis to generate a
complex ductal system surrounded by a complex periductal
stroma. The ducts of the mature prostate are lined by a
differentiated luminal epithelium with at least three major cell⁎ Corresponding author. Fax: +1 608 265 8133.
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doi:10.1016/j.ydbio.2007.09.042types. Basal cells express cytokeratins 5 and 14, and
transformation-related protein 63 (p63) (Hayward et al., 1996;
Yang et al., 1998; Wang et al., 2001; Kurita et al., 2004).
Luminal epithelial cells express cytokeratin 8 and 18 and secrete
prostate-specific proteins such as probasin (Cussenot et al.,
1998; Johnson et al., 2000). Epithelial cells co-expressing
cytokeratins 5, 14, 8, and 18 are hypothesized to represent either
intermediates of the basal to luminal cell lineage (Cussenot
et al., 1998; Peehl et al., 1994; Verhagen et al., 1988) or a
pleuripotent progenitor cell population (Wang et al., 2001). The
adult prostate is an androgen-dependent organ. In response to
castration, there is widespread epithelial apoptosis and involu-
tion preferentially affecting the distal duct segments. Testoster-
one supplementation induces complete regeneration of the
prostate ductal system by stimulating outgrowth from the spared
proximal duct segments (Sugimura et al., 1986).
The regenerative potential of the adult prostate fueled early
efforts to identify prostate-specific stem cells. Early studies by
Kinbara and colleagues (1996) demonstrated that epithelial cells
isolated from different lobes of the adult rodent prostate
exhibited features expected of stem cells, including enormous
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epithelial differentiation. These characteristics recapitulated the
progenitor phenotype of epithelial cells isolated from the UGS
prior to the induction of prostate development and suggested a
functional equivalence between them. A number of studies of
tissue-specific stem cells in the adult prostate followed
(Robinson et al., 1998; Hudson et al., 2000; Collins et al.,
2001; Foster et al., 2002) and Tjusimura et al. (2002) performed
in vivo labeling during postnatal prostate development followed
by multiple rounds of castration-regeneration to localize label-
retaining cells within the adult prostate. These efforts demon-
strated that label-retaining cells localized preferentially to the
proximal segments of the prostate ducts, and subsequent studies
using in vivo recombination techniques demonstrated that the
regenerative capacity of the adult prostate epithelium was
predominantly located in the proximal duct segments (Burger et
al., 2005; Xin et al., 2005). More recent efforts have focused on
identifying specific stem cell markers. Richardson et al. (2004)
identified CD-133 as a putative stem cell marker. Stem cell
antigen-1 (Sca-1) was also identified as a putative stem cell
marker in prostate, and the proximal duct segments were shown
to be enriched for cells co-expressing Sca-1 and α6-integrin
(Burger et al., 2005). More recent efforts used FACS to isolate
cells expressing combinations of these stem cell markers to
enrich for epithelial cells with increased regenerative potential
(Lawson et al., 2007). The regenerative potential of epithelial
cells from the proximal duct segments can be maintained
through serial passages in vivo and correlates with formation of
viable spheres in a collagen gel assay (Goto et al., 2006; Lawson
et al., 2007); however, successful culture and passage of bona
fide progenitor cells in vitro have not been previously reported.
In the studies reported here, we show that epithelial cells
isolated from the E16 UGS, the P1 prostate, and the adult
prostate all generate viable and proliferating spheres of cells
when plated in anchorage-independent culture. The “prosta-
spheres” were morphologically indistinguishable, could be
serially passaged in vitro, and generated glandular tissue with
characteristic prostatic histology and expression of terminal
differentiation markers when recombined with embryonic rat
UGS mesenchyme (rUGM) in vivo. We show that epithelial
cells isolated from the adult prostate and cultured in anchorage-
independent conditions recapitulate the differentiation potential
of UGS epithelial cells and show, furthermore, that in utero
BrdU labeling of the urogenital epithelium yields a fraction of
label-retaining basal epithelial cells in duct segments of the
adult prostate. Taken together, these findings suggest that slow-
cycling progenitor cells of the adult prostate epithelium may
derive, at least in part, from a subpopulation of cells that
actively proliferate during early prostate development.
Materials and methods
Animals
Animal procedures were performed in accordance with the guidelines of the
University of Wisconsin-Madison's Animal Care and Use Committee. CD-1
wild-type and nude mice were purchased from Charles River Laboratories
(Wilmington, MA) unless otherwise stated. The actin-EGFP (C57 BL/6 TG(ACTB-EGFP/1Osb/j, stock # 003291) was ordered from The Jackson
Laboratory (Bar Harbor, ME). Mice were sedated with isoflurane, euthanized
by cervical dislocation, and UGS and prostates were harvested by dissection in
Dulbecco's PBS (Invitrogen, Carlsbad, CA). Tissue samples were either snap
frozen in liquid nitrogen and stored at −80 °C for RNA isolation or fixed in 4%
paraformaldehyde.
BrdU labeling
The developing prostate was labeled in utero by IP injection of 0.5 ml BrdU
(10 mM) per mouse as instructed (Roche Diagnostic GmbH, Mannheim,
Germany).
Prostasphere generation
E16 UGS tissues were treated with 1% trypsin (GIBCO, Cat. #27250-018,
Invitrogen, Carlsbad, CA) for 60 min at 4 °C, and the epithelium and
mesenchyme were mechanically separated as previously described (Lamm et al.,
2001). The isolated epithelium was treated with 0.5% collagenase Type I
(GIBCO, Cat. #17100-017, Invitrogen, Calsbad, CA), dissociated using a fire-
polished glass Pasteur pipette, and passed through a 40 μm cell strainer to
produce a single cell suspension. Cells were plated on a standard cell culture
plate for 60 to 120 min at 37 °C to remove contaminating mesenchymal cells
detected by RT-PCR for the expression of the mesenchyme-specific marker
BMP4 (Ravindranath and Dym, 1999; Lamm et al., 2001).
The isolated anterior (AP), ventral (VP), and dorsal–lateral prostate (DLP)
lobes of the adult prostate were minced to 1 mm pieces, digested with 1%
collagenase in DMEM media with 10% FBS 37 °C for 30 min; the prostate
tissues were digested in 1% collagenase and 0.5% hydrouronidase for another
30 min and incubated in PBS containing 1% trypsin for 30 to 60 min. The
separated cells were collected and passed through a 40 μm cell strainer to
produce a single cell suspension and counted using a hemocytometer. Plating on
monolayer tissue culture dishes with DMEM/F12media supplemented with 10%
FBSwithout DHT for 12 to 14 hwas used to remove contaminating stromal cells.
The epithelial cells remaining in the supernatant were collected and grown on
ultralow attachment plates (Corning Inc., Acton, MA) to generate prostaspheres.
The isolated cells were cultured at the density of 500 cells/ml (unless stated
otherwise) in 100 mm diameter ultralow attachment plates with 20 ml sphere
culture media. The sphere culture media are serum free DMEM/F12 50/50
(Mediatech, Inc., Harndon, VA, Cat. #10-090-CV) supplemented with 20 ng/ml
EGF (BD Biosciences, MA), 10 ng/ml bFGF (BD Biosciences, MA), 5 μg/ml
heparin (Sigma, MO), 2 nM Glutamate (Sigma, MO), other components of the
media include 1% penicillin–streptomycin (50 IU penicillin and 50 μg/ml
streptomycin, Mediatech, Inc., Harndon, VA, Cat. #30-001-CI), 0.2% bovine
serum albumin (BSA, Fisher, Cat. #9048-46-8), 1× B27 without Vitamine A
(GIBCO, 12578-010), and 1× Insulin-Transferrin-Selenium-A (Gibco/BRL
51300-044). The sphere culture media were changed every 72 h until the
majority of prostaspheres reached 200–300 μm in diameter (approximately
15 days). For monolayer culture, the same number of cells was plated in either
serum free prostate epithelial cell culture media supplemented with defined
growth factors (PrEBM, from Cambrex, Walkersville, MD) or DMEM/F12 with
1% FBS supplemented with 20 ng/ml of EGF.
Passage of prostaspheres
Prostaspheres were collected by gentle centrifugation (400×g for 5 min)
dissociated with 0.25% trypsin-EDTA and mechanically disrupted with a fire-
polished Pasteur pipette. The cell suspension was sieved through a 40 μm cell
strainer, plated on a monolayer culture plate for 60 min to remove contaminating
stromal cells, and then re-plated.
Cell count
Sphere diameter and cell number were determined for 20 prostaspheres on
day 3, 6, 9, 12, and 15 of culture. Prostasphere diameter was determined by
digital imaging through a dissecting microscope and measured using an NIH
image analysis program (http://rsb.info.nih.gov/nih-image/). Cell number was
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counting on a hemocytometer.
Renal grafts
Thirty to forty second generation (G2) prostaspheres or an equivalent
number of cells (∼100,000 cells) generated from E16 UGS or adult prostate
epithelial cells were mixed with freshly isolated E17 rat UGM (rUGM) and 40 μl
of neutralized rat-tail collagen, incubated at 37 °C for 2 h and grafted under the
renal capsule of an adult male nude mouse. The details for recombinant
generation and grafting are described (Shaw et al., 2006). Forty microliters of
neutralized rat-tail collagen was mixed with prostasphere-only or rUGM-only
and grafted as controls. Grafted tissues were harvested 4, 8, or 12 weeks, and
half were fixed for sectioning and half snap frozen.
Histology
Dissected tissues were fixed in 4% paraformaldehyde overnight at 4 °C, and
5 μm sections were obtained, dewaxed, and stained with Mayer's hematoxylin
and eosin (H&E) for histological evaluation. Examination was performed on at
least 10 fields from each of 5 sections per graft to determine the presence or
absence of glandular structures.
Hoechst 33258 staining
Dewaxed tissue sections were stained with Hoechst 33258 according to
methods described previously (Cunha and Vanderslice, 1984).
Indirect immunofluorescent staining
Dewaxed sections were blocked with 3% BSA plus 10% goat or monkey
normal serum (secondary antibody species). The primary antibody was added in
blocking buffer (3% BSA in PBS) at concentration and incubation time listed
below. The primary antibodies were: Mouse anti-E-cadherin (BD Biosciences,
1:200, Cat. #612130, room temperature 1 h); Rabbit anti-Ki67 (Vector, 1:100,
Cat. #VP-K451, 4 °C overnight); Mouse anti-SMA (Sigma. 1:200, Cat. #A5228;
room temperature 1 h); Mouse anti-CK14 (Biogenix, 1:200, Cat. #AM146; 4 °C
overnight); Mouse anti-p63 (Santa Cruz, 1:50, Cat. #SC8431; 4 °C overnight);
Goat anti-Probasin (Santa Cruz, 1:200, Cat. #SC17124; room temperature 2 h);
Rabbit anti-Androgen Receptor (Santa Cruz, 1:250, Cat. #SC-816; 4 °C
overnight); Rabbit anti-GFP (Chemicon, 1:100; Cat. #B3080; 4 °C overnight);
Mouse anti-BrdU (Roche, 1:10, Cat. #1299964; 37 °C 30 min); Rabbit anti-
chromogranin A (Zymed, 1:100, Cat. #18-0094; 4 °C overnight). After washing
3 times with PBS, the secondary antibody was added and incubated at room
temperature for 1 h. All secondary antibodies were diluted 1:200 in blocking
buffer. The secondary antibodies were: Goat anti mouse Alexa 488 (Molecular
Probes, Cat. #A11029); Goat anti rabbit Alexa 546 (1:200, Molecular Probes,
Cat. #A11035); Donkey anti-rabbit Alexa 594 (1:200 Molecular Probes, Cat.
#A21207); Donkey anti goat Alexa 546 (1:200 Molecular Probes, Cat.
#A11056). Fluorescent images were captured using an Olympus-BX51
fluorescent microscope (Olympus, Center Valley, PA).
RT-PCR
RNA was prepared using QIAshredder (QIAGEN, Valencia, CA) and
RNeasy mini kit (QIAGEN, Valencia, CA) according to the manufacturer's
instructions. One microgram of RNA was subjected to reverse transcription
using SuperScript III first-strand cDNA synthesis system (Invitrogen, Carlsbad,
CA) in a volume of 25 μl. Real-time PCR was carried out in an iCycler Thermal
Cycler (Bio-Rad, Hercules, CA) using SYBR green (Applied Bioscience, Foster
City, CA). The data were normalized with a GAPDH internal control. The
primers used for mouse species-specific quantitative PCR were:
Sca-1 Forward 5′-CCATCAATTACCTGCCCCTA-3′
Sca-1 Reverse 5′-GGCAGATGGGTAAGCAAAGA-3′
CD-133 Forward 5′-GAAAAGTTGCTCTGCGAACC-3′
CD-133 Reverse 5′-TCTCAAGCTGAAAAGCAGCA-3′α6-Integrin Forward 5′-AGCCCCAGGGACTTACAACT-3′
α6-Integrin Reverse 5′-CTTCATAGGGCCCATCTTCA-3′
Spermine binding protein Forward 5′-AGAGCCCAGAATGTCCTGGG-3′
Spermine binding protein Reverse 5′-TTATCACGTGCTCTCCGTCC-3′
Beta-microseminoprotein (PSP94) Forward 5′-TGG CTG GGC AGT CTC
TTA TT-3′
Beta-microseminoprotein PSP94 Reverse 5′-AGC ATC CAT GCA GTC
ATC AG-3′
mGAPDH Forward 5′-GCAGTGGCAAAGTGGAGATT-3′
mGAPDH Reverse 5′-CGTTGAATTTGCCGTGAGTG-3′
mProbasin Forward 5′-GGA GGA GAT GAC GGA GTT CA-3′
mProbasin Reverse 5′-ACA GTT GTC CGT GTC CAT GA-3′
mNKX3.1 Forward 5′-GAA AGC AGC TGT CGG AAG AC-3′
mNKX3.1 Reverse 5′-CGG AGA CCA AGG AGG TAC TG-3′
Statistical analysis
Statistical analysis of prostasphere generation, prostasphere growth, and
gene expression data was performed using unpaired t-test with assistance from
the UW Madison Department of Surgery's Statistical Core.
Results
The epithelial layer of the E16 CD-1 mouse UGS was
mechanically and enzymatically isolated, dissociated, and
sieved to obtain a single cell suspension. Each UGS yielded
approximately 2000–4000 epithelial cells. When 10,000 cells
were plated at low density in ultralow attachment plates in EGF
and bFGF supplemented serum free media without DHT, they
formed floating spheres of proliferating cells with an average of
60 spheres being generated from 10,000 cells. Histological
examination of spheres revealed nearly solid spheres of viable,
undifferentiated cells that increased progressively in diameter
(Fig. 1). After 15 days growth in culture, the prostaspheres were
collected by gentle centrifugation, dissociated, and sieved and
re-plated at low density. The efficiency of sphere formation
from the passaged cells was approximately 300 spheres from
10,000 cells, indicating an enhanced capacity for sphere
formation among the cultured cells (Fig. 1D). This enhanced
capacity for sphere formation persisted for several passages.
There was a progressive decrease in sphere-forming efficiency
and sphere growth rate after the 5th generation (not shown).
Even so, spheres could be serially passaged for up to 10
generations.
We next examined the effect of plating density on sphere
formation and growth. First generation prostaspheres were
dissociated into single cells and plated at densities of 100, 500,
1000, 2500, 5000, and 10,000 cells per ml of culture media.
Cells and spheres were observed daily, and the increase in
average cell number and diameter of prostaspheres was
measured over the time course of culture. When cells were
plated at low density (500 cells per ml culture media),
microscopic examination performed within 24 h revealed
mostly single cells. Multicellular bodies appeared on day two,
and there was a progressive increase in mean sphere diameter
over 15 days. Measurements of sphere diameter and average
number of cells/sphere produced linear curves on a semi-log
plot. These curves closely approximated the predicted curves
for an increase in sphere diameter from cell proliferation using a
doubling time of 30 h and the formula (4/3πR3) / (4/3πr3), where
Fig. 1. A single cell suspension of E16 epithelial cells cultured in anchorage-independent conditions exhibited growth in spheres. (A, B) Serial photographs during
culture demonstrated progressive increase in prostasphere diameter. (C) Second generation prostaspheres from the E16 UGS were fixed in 4% paraformaldehyde,
coated with collagen, paraffin embedded, and sectioned (4 um) and stained with H&E. (D) Efficiency of sphere formation on serial passage, for example from first
generation to second generation (G1–G2), plotted as the number of prostaspheres generated from 10,000 epithelial cells.
Fig. 2. Cells were plated at in anchorage-independent conditions at a density of
500 cells per ml culture media and the increase in average cell number and
diameter of prostaspheres measured daily. (A) Average number of cells per
prostasphere. (B) Average diameter of prostaspheres. Data represent average of
three independent experiments.
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diameter of an epithelial cell (Fig. 2). These data indicate that
sphere growth under these conditions results primarily from cell
proliferation rather than amalgamation between spheres. The
ability of single cells to form clonal spheres was confirmed by
plating cells at low density in methylcellulose based colony
assay media to prevent cell movement. We observed compar-
able efficiencies of sphere formation under these restrictive
conditions (data not shown). Significant amalgamation can
occur when cells are plated in anchorage-independent condi-
tions at high-density (N4000 cells/ml). Under these conditions,
we observed multicellular bodies within 24 h of plating, and
both sphere diameter and average number of cells/sphere
increased at a faster rate than predicted (data not shown). Since
these data indicate plating at low density favors clonal sphere
formation and discourages amalgamation, cells were plated at
500 cells per ml culture media for all subsequent experiments.
To determine whether culture of epithelial cells in ancho-
rage-independent conditions enriches for cells expressing
putative stem cell markers as compared to culture of cells in
monolayer dishes, we examined the expression of several
putative prostate stem cell markers including Sca-1, CD-133,
and α6-integrin (Richardson et al., 2004; Xin et al., 2005;
Burger et al., 2005; Lawson et al., 2007). A single cell
suspension made from enzymatically dissociated second
generation (G2) prostaspheres was plated on either ultralow
attachment plates or mammalian tissue culture plates and grown
for 14 days. Comparison of gene expression by RT-PCR
showed significantly higher expression of Sca-1 and CD-133 in
cells grown in anchorage-independent conditions (Fig. 3). The
Fig. 3. Cells isolated from second generation (G2) prostaspheres were cultured
in either ultralow attachment plates or mammalian monolayer cell culture plates
and gene expression determined by RT-PCR. ⁎Pb0.05.
Fig. 4. (A) Prostasphere-forming ability epithelial cells of the E16 UGS, P1, and ad
number of spheres formed after 9 days. ⁎Pb0.05. (B–D) Stem cell marker mRNA exp
RT-PCR. a, b, and c denote groups with significantly different levels of expression
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prostasphere-cultured cells but the difference was not statisti-
cally significant.
We next compared the prostasphere-forming ability of
epithelial cells isolated from prostate tissue of various ages.
Epithelial cells isolated from the E16 UGS, the P1 prostate, and
adult prostate formed spheres in anchorage-independent culture
that were morphologically and histologically indistinguishable
(data not shown). Cells derived from the E16 UGS showed
modestly higher (b2-fold; Pb0.05) prostasphere-forming
ability than cells isolated from either the P1 or adult prostate
(Fig. 4A). Examination of gene expression by RT-PCR in the
developing and adult prostate showed a marked increase in Sca-
1 expression from E14 to P5 and robust expression in all three
lobes of the adult prostate. In contrast, there was little change in
the expression of CD-133 and α6-integrin through most of the
developmental stage, but the expression of both was modestly
increased in the adult anterior prostate (AP) and dorsal–lateral
prostate (DLP) (Figs. 4B–D).
The adult prostate exhibits widespread epithelial apoptosis
and involution in response to castration and robust re-growth in
response to subsequent androgen supplementation. Tissue-
specific stem cells are postulated to be androgen-independent
and to serve as the basis for epithelial repopulation during
androgen-induced re-growth. When we examined the effect of
castration on expression of Sca-1, CD-133, and α6-integrin, we
did not observe any consistent pattern of changes (Figs. 5A–C).
However, when we compared the prostasphere-forming ability
of epithelial cells isolated from the three lobes of the prostate in
castrated and sham operated mice, we observed a significantly
higher efficiency of prostasphere formation in cells isolatedult prostate was determined by plating 10,000 epithelial cells and counting the
ression in the E14 and E16 UGS and the P1, P5, and adult prostate determined by
(a and b: Pb0.05; b and c: Pb0.05; a and c: Pb0.01).
Fig. 5. Stem cell marker gene expression level is not a good indicator for stem cell activity. Adult mice were castrated or sham-castration as control. AP, VP, and DLP
were isolated to assess stem cell marker gene expression or prostasphere-forming ability assay. (A–C) Stem cell marker expression in the castrated and sham-operated
adult prostate. (D) Sphere-forming ability of epithelial cells isolated from the different prostate lobes of the intact adult and 14 days after castration. ⁎Pb0.01.
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the observed increase is comparable to the enrichment for stem
cells as calculated by other methods, including in vivo grafting
assays and soft agar cloning assays (Lawson et al., 2007),
suggesting that prostasphere-forming efficiency may serve as a
surrogate measure of stem cell activity.
To determine whether prostaspheres contain bona fide
epithelial progenitor cells, we examined their regenerative
potential in vivo. We first assayed the ability of prostaspheres
alone to regenerate prostate tissue. Approximately 30–40 G2
prostaspheres (equivalent to 100,000 cells) derived from either
the E16 UGS (n=3) or adult prostate (n=4) were mixed with
30 μl rat-tail collagen and grafted under the renal capsule of a
male nude mouse. Histological examination of the grafts 4
weeks later showed no evidence of prostatic duct formation and
RT-PCR assay revealed no expression of prostate-specific
markers (data not shown).
We then tested the ability of prostaspheres to regenerate
prostate tissue when grafted together with E17 rUGM. G2
prostaspheres derived from either E16 mouse UGS or adult
mouse prostate epithelial cells were grafted with embryonic
rUGM to the renal capsule of male adult nude mouse, and the
grafted tissue was retrieved after 4, 8, and 12 weeks growth in
vivo. After 4 weeks in vivo growth, the grafts exhibited ductal
development with some canalized lumina. Glandular lumina
were larger in renal grafts grown for 8 and 12 weeks and
contained large amounts of luminal secretion. Grafting of G2
prostaspheres derived from E16 mouse UGS (n=5) or adult
mouse prostate epithelial cells (n=10) together with rUGM
consistently yielded recombinant grafts with characteristic
prostate glandular morphology (Figs. 6A, C, D). Neither grafts
of rUGM alone (not shown) nor grafts of rUGM combined withG1 cells cultured in monolayer for 14 days (n=7) generated any
tissues with prostate-like morphology (Figs. 6E, F). Several
other investigators have found that prostate epithelial cells can
maintain the ability to regenerate prostate ducts in recombina-
tion assays. Some of these studies utilized an established
epithelial cell line, while others used epithelial cells isolated
from the retinoblastoma null mouse or transformed cancer cell
lines (Hayward et al., 1999; Day et al., 2002; Gu et al., 2007).
The reason for the discrepancy with our observations using
primary epithelial cells cultured in monolayer is unknown, but
may relate to separation of the primary epithelial cells from
stromal cells or the monolayer culture conditions. The mouse
origin of the glandular epithelium in recombinant grafts was
demonstrated by three independent methods. We stained grafts
with Hoechst 33258 to distinguish cells of mouse and rat origin
(Cunha and Vanderslice, 1984), and observed brightly speckled
staining of the nuclei in the glandular epithelium consistent with
mouse origin (data not shown). We made prostaspheres from the
adult prostate of the GFP mouse, recombined G2 prostaspheres
with rUGM, and immunostained the matured grafts for GFP
(Fig. 7A). Finally, we performed RT-PCR for the prostate
epithelial markers Nkx3.1 and Probasin (Doles et al., 2005)
using mouse species-specific primers (Fig. 7B). Immunostain-
ing was performed for several epithelial and stromal markers,
confirming the expression of androgen receptor in the glandular
epithelium, expression of smooth muscle actin in the peri-
glandular stroma, showing the presence of neuroendocrine
cells, demonstrating the presence of the basal cell markers p63
and CK14, and showing robust staining for probasin peptide in
the luminal epithelium (Fig. 8). This expression was not
observed in grafts made by combining cells cultured in
monolayer and subsequently grown in vivo with rUGM. To
Fig. 6. Second generation prostaspheres or monolayer-cultured cells were mixed with E17 rUGM and grafted under renal capsule of an adult male nude mouse. Grafted
tissues were retrieved 8 weeks later. The representative photomicrograph of retrieved tissue from (A) prostasphere and (B) monolayer-cultured prostate epithelial cells
grafted with rUGM. H&E stained tissue sections show mouse glandular epithelial ducts developed from prostasphere-cultured epithelial cells with rUGM (C and D)
but not from prostasphere only (E) or monolayer-cultured cells with rUGM (F).
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anchorage-independent conditions was maintained through
serial passage, we performed tissue recombination assays
using third (G3) and fourth (G4) generation prostaspheres.
The result demonstrated that prostaspheres maintain their
regenerative capacity through 4 passages, but with a diminish-
ing rate of success at later passages (Table 1).
We next tested whether cells grown in prostaspheres exhibit
the plasticity expected of primitive prostate progenitor cells by
determining whether cells isolated from one lobe can be re-
programmed to express genes specific for another lobe. Prostate
epithelial cells were isolated from either ventral or dorsal–
lateral prostate, cultured as prostaspheres, then mixed with E17Fig. 7. (A) Prostaspheres generated from adult GFP transgenic mice were recombine
weeks later. Immunostaining with GFP (red) demonstrated that glandular epithelial d
small number of stromal cells also stain positive for GFP. BrdU staining (green) indic
performed using mouse species-specific primers to probasin and NKX3.1. The expre
prostaspheres combined with rUGM than in grafts made with monolayer cells.rUGM and grafted to the renal capsule of a male nude mouse.
The expression level of VP marker spermine binding protein
(SBP) and lateral prostate marker beta-microseminoprotein
(PSP94) was determined by RT-PCR (Lin et al., 2002), and
probasin expression was used to normalize terminal differentia-
tion and overall growth and development of grafted tissue. The
results showed that there is no statistical significance in
expression levels of SBP and PSP94 in grafts made with cells
isolated from VP or DLP (Fig. 9). In adult mouse prostate, DLP
does not express SBP; however, prostasphere-cultured epithe-
lial cells isolated from DLP express SBP when combined with
embryonic rUGM and grown in vivo. This result demonstrates
that progenitor cells isolated from DLP maintained the ability tod with E17 rUGM and grafted. BrdU labeling was performed prior to harvest 8
ucts were derived from prostasphere-cultured mouse prostate epithelial cells. A
ated proliferation of both epithelial and stromal cells. (B) Real-time RT-PCR was
ssion levels of Probasin and Nkx3.1 are N1000-fold higher in grafts made from
Fig. 8. Immunostaining of grafts made with second generation prostaspheres for markers of prostate stromal and epithelial differentiation, including (A) E-cadherin,
(B) Smooth muscle actin, (C) Cytokeratin 14 (CK14), (D) p63, (E) Probasin, (F) Androgen receptor, and (G) Chromogranin A.
403X. Shi et al. / Developmental Biology 312 (2007) 396–406express genes specific to VP. This is in agreement with previous
studies that UGM is both a ventral and a dorsal inducer (Kinbara
et al., 1996).
This experiment demonstrated that cells isolated from the
adult prostate and cultured in anchorage-independent conditions
exhibit the pleuripotent differentiation phenotype of the
urogenital sinus epithelium. This observation prompted us to
explore the possibility that slow-cycling (label-retaining) cells
of the adult prostate, which have been implicated as quiescent
stem or progenitor cells (Tjusimura et al., 2002) are descendents
of urogenital sinus epithelial cells that undergo limited
proliferation during early prostate development. We labeled
the developing prostate in utero by BrdU administration at E16.
Prostate tissues were harvested at selected time points during
development (P1, P5, P15, P30, and adult), sectioned, and
immunostained for BrdU. There was generous labeling of both
epithelial and mesenchymal cells at early time points (not
shown). The percentage of labeled epithelial cells progressively
diminished during postnatal development but a small number of
strongly labeled cells persisted in the ductal epithelium of theTable 1
Prostasphere-cultured prostate epithelial cells tissue regenerative ability
Passage of
prostaspheres
Number of tissue
renal grafted (n)
Glandular epithelial
ducts developed a (n)
Rate (%)
G2 15 14 93.3
G3 12 9 75.0
G4 6 4 66.7
a Based on histology, RT-PCR, and immunostaining. No glandular epithelial
ducts developed in control groups.adult prostate and usually co-stained for the basal cell marker
p63 (Fig. 10).
Discussion
The use of grafting of the UGS to the renal capsule for the
study of prostate development was pioneered by Cunha (1972)
and Turner et al. (1990) who reported that adult mouse prostate
epithelial cells grown in collagen can regenerate prostate when
combined with rUGM. The studies reported here validate
anchorage-independent culture as a reliable method to maintain
and grow prostate progenitor epithelial cells in vitro. Our
studies provide a sorely needed methodology to enable detailed
studies of prostate stem cell biology. We recently showed that
grafting of the UGS under the renal capsule faithfully recapi-Fig. 9. Prostaspheres generated from epithelial cells isolated from VP or DLP
grafted with E17 rUGM generate prostate tissue expressing equivalent levels of
VP- and DLP-specific markers SBP and PSP94, respectively. SBP and PSP94
gene expression was normalized to probasin expression for each grafts.
Fig. 10. In utero BrdU labeling was performed at E16. BrdU labeled prostate tissue was collected 8 weeks later, paraffin embedded, sectioned, and immunostained for
BrdU and p63. (A) Control without any primary antibody. (B) Tissue stained for both BrdU (green) and p63 (red). Small numbers of label-retaining epithelial cells are
observed that co-stain for BrdU and p63 (inset).
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et al., 2005) and variations of this technique have been used
previously by others to evaluate stem cell function in isolated
prostate epithelial preparations (Xin et al., 2005; Burger et al.,
2005). We employed a combined strategy including immuno-
histochemical staining and RT-PCR using species-specific
primers to demonstrate that prostasphere-derived epithelial
cells generated prostate glandular epithelium containing both
basal and luminal cells and exhibiting robust expression of
terminal differentiation markers. Physical separation of the
E16 UGS epithelium and mesenchyme is an efficient way to
obtain a highly purified epithelial cell preparation. We began
our studies of anchorage-independent culture with fetal
epithelial cells obtained in this way so as to minimize stromal
cell contamination. We subsequently developed the methodol-
ogy to create a highly purified population of epithelial cells
from the P1 and adult prostate and demonstrated that cells
from all three ages generated prostaspheres with comparable
efficiency and with the same capacity to generate fully
differentiated prostate epithelium when recombined with fetal
mesenchyme. Despite our efforts to eliminate contaminating
stromal cells, immunostaining for stromal and epithelial
markers showed that some prostaspheres contain both
epithelial and stromal cells (data not shown). This may not
be unexpected since the growth of stromal cells would be
more robust than the epithelial component. The separation of
stromal from epithelial cells is never complete and so some
stromal cells may be contained in the epithelial portion. One
might also speculate that progenitor cells can give rise to both
stromal and epithelial lineage. Indeed, GFP staining of
prostasphere-derived cells from the GFP mouse recombined
with rUGM and grafted into a nude host mouse showed a
small number of GFP+ stromal cells in the resulting graft
(Fig. 7). Stromal cell contamination is the most probable
explanation for this finding. We cannot exclude the possibility
of a common progenitor for epithelial and stromal cell
lineages; however, our finding that prostaspheres grafted
without rUGM do not generate prostate glandular tissue argues
against this possibility. Our studies, like other recent studies of
neurosphere formation (Reynolds et al., 1992; Reynolds and
Weiss, 1996; Singec et al., 2006), suggest that prostaspherescan be formed either from a single cell or by a process of
amalgamation depending on the density at which the cells are
plated. We speculate that some amalgamation occurs, even
when cells are plated under dilute conditions, producing some
spheres of multi-cellular origin including both epithelial and
stromal cells.
Previous studies have suggested that the stem cell or
primitive progenitor cells of the adult mouse prostate are
concentrated in the proximal duct segments (Tsujimura et al.,
2002; Burger et al., 2005; Salm et al., 2005; Goto et al., 2006;
Xin et al., 2005; Lawson et al., 2007). Tsujimura et al. (2002)
utilized BrdU pulse labeling at 3 weeks postnatal followed by
multiple rounds of castration-induced regression and testoster-
one-induced regeneration to demonstrate the presence of slow-
cycling cells in the prostate ductal epithelium. This population
of cells, which localized preferentially to the proximal duct
segments, was postulated to include the primitive progenitor
cells of the adult prostate epithelium. Subsequent studies appear
to have confirmed this inference. The epithelium of the
proximal duct segments has been shown to be enriched in
regenerative potential. Sca-1+ cells have been shown to contain
a subpopulation of cells coexpressing α6-integrin (Burger et al.,
2005). FACS sorting for Sca-1 and α6-integrin enriches for
epithelial cells with regenerative potential in tissue recombina-
tion assays and soft agar cloning assay (Burger et al., 2005;
Lawson et al., 2007). CD-133 has also been proposed as a
prostate epithelial stem cell marker, but the relationship
between CD-133 and other prostate stem cell markers has not
been fully explored (Richardson et al., 2004). Although prostate
epithelial cells quickly lose their regenerative potential when
placed into monolayer, our studies suggest that sphere culture
allows the survival and proliferation of epithelial cells that
include a population of bona fide progenitor cells. We noted
that culture under these conditions is associated with main-
tained expression of the putative stem cell markers Sca-1,
α6-integrin, and CD-133.
However, our studies show that stem cell marker mRNA
expression by itself is an unreliable index for progenitor cell
activity. Castration of the adult mouse induces apoptosis of
terminally differentiated, androgen-dependent prostate luminal
epithelial cells while sparing the androgen-independent cells
405X. Shi et al. / Developmental Biology 312 (2007) 396–406that include basal cells and some luminal cells (Reuter, 1997).
Rapid regeneration of the glandular epithelium occurs in
response to administration of exogenous testosterone and
several different assays have shown that epithelial cells of the
castrate prostate possess higher regenerative potential compared
to cells from intact adult prostate (Xin et al., 2005; Lawson et
al., 2007). We found that castration-induced regression of the
adult prostate was associated with only a moderate change in the
mRNA expression levels of stem cell markers, even though we
observed significantly increased efficiency of sphere formation
by cells isolated from all three prostate lobes of the castrated
mouse suggesting that sphere formation can be used as a
surrogate index of progenitor cell content (Fig. 5). In profiling
expression of Sca-1, α6-integrin, and CD-133 expression from
E14 to adult, we noted a progressive rise in Sca-1 expression
along with modest increases in CD-133 and α6-integrin
expression (Fig. 4). In contrast, sphere-forming efficiency was
actually slightly lower for epithelial cells isolated from either
the P1 or adult prostate than for cells isolated from the E16 UGS
(Fig. 4). These findings indicate that global measures of stem
cell marker mRNA expression do not correlate with progenitor
cell activity and reinforce the notion that it is demonstrated
epithelial co-expression of surface markers such as Sca-1 and
α6-integrin that is the distinguishing feature of prostate
epithelial progenitor cells.
Our studies revealed that some of the UGS epithelial cells
pulse-labeled at E16 take up residence as slow-cycling cells
in the adult prostate. This observation prompts us to speculate
that these slow-cycling cells are a component of the adult
prostate epithelial stem cell population (Fig. 10). This concept
that resonates with previous studies by Wang et al. (2001)
suggesting the presence of functionally equivalent stem cells
in the UGS epithelium and adult. It also is consistent with the
shared capacity, demonstrated here, for epithelial cells from
the E16 UGS and adult prostate to form spheres in
anchorage-independent culture that exhibit an equivalent
potential for lobe-specific differentiation in tissue recombina-
tion studies. Following the studies of Cunha (1972), Norman
et al., 1986 demonstrated that isolated epithelium from the
adult prostate combined with embryonic UGM can form
prostate tissue in grafts. These studies suggested an
equivalence between cells in UGS and adult prostate tissue.
Several studies have highlighted the role of stem cells in brain
and mammary gland development (Fricker-Gates et al., 2004;
Liu et al., 2005; Chepko and Smith, 1999), but our studies
provide the first evidence that suggests equivalence between
stem cells in the developing and adult prostate and, as such,
opens the way to using the well characterized and tractable
system of prostate development for the study of stem cell
regulation and function.
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